Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Prime Medicine (PRME) Net Margin (2024 - 2025)

Historic Net Margin for Prime Medicine (PRME) over the last 2 years, with Q3 2025 value amounting to 4129.14%.

  • Prime Medicine's Net Margin rose 209990900.0% to 4129.14% in Q3 2025 from the same period last year, while for Sep 2025 it was 3301.64%, marking a year-over-year increase of 241044900.0%. This contributed to the annual value of 6566.61% for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Prime Medicine's Net Margin is 4129.14%, which was up 209990900.0% from 4716.68% recorded in Q2 2025.
  • In the past 5 years, Prime Medicine's Net Margin registered a high of 1936.6% during Q4 2024, and its lowest value of 25128.23% during Q3 2024.